NIH Issues Draft of Guidelines Governing Stem Cell Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

BETHESDA, Md-The National Institutes of Health has proposed a set of guidelines aimed at ensuring the ethical and legal conduct of any embryonic and fetal stem cell research that it funds.

BETHESDA, Md—The National Institutes of Health has proposed a set of guidelines aimed at ensuring the ethical and legal conduct of any embryonic and fetal stem cell research that it funds.

The guidelines sanction research on cell lines from fetal tissue, work that develops new cells lines from fetal tissue, and research on cell lines privately derived from human embryos.

The guidelines prohibit studies that would create or contribute to a human embryo, combine human stem cells with an animal embryo, or engage in reproductive cloning of a human. Also barred are studies in which stem cells are derived using somatic cell nuclear transfer into a human or animal egg, and those in which stem cells are derived from human embryos created for

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
1 expert in this video
1 expert in this video
1 expert in this video
Testing a patient’s genetics may influence decisions such as using longer courses of radiotherapy, says Rachit Kumar, MD.
Related Content